Detalles de la búsqueda
1.
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
BJU Int
; 133 Suppl 3: 57-67, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986556
2.
Exploring the practicality and acceptability a brief exercise communication and clinician referral pathway in cancer care: a feasibility study.
BMC Health Serv Res
; 23(1): 1023, 2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740170
3.
Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future.
Cancers (Basel)
; 14(6)2022 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326557
4.
Bridging the gap between attitudes and action: A qualitative exploration of clinician and exercise professional's perceptions to increase opportunities for exercise counselling and referral in cancer care.
Patient Educ Couns
; 105(7): 2489-2496, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823926
5.
Cancer survivors' exercise beliefs, knowledge, and behaviors: An Australian National Survey.
Asia Pac J Clin Oncol
; 18(6): 625-633, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098655
6.
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
Immunotherapy
; 14(7): 511-520, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321560
7.
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer.
Eur J Cancer
; 47(9): 1343-54, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21550229
Resultados
1 -
7
de 7
1
Próxima >
>>